Literature DB >> 12191618

Inhibition and activation of c-Src: the head and tail of a coin.

Yasuo Fukami1, Tomomi Nagao, Tetsushi Iwasaki, Ken-ichi Sato.   

Abstract

Protein-tyrosine kinases (PTKs) play pivotal roles in many cell systems. The Src family kinases (SFKs) are the most characterized PTKs shown to be coupled with various cell surface receptors. However, their mode of activation and regulating partners are largely unknown. Here we describe a novel mechanism of inhibition and activation of c-Src, a representative of the SFKs. Both directions of regulation take place at the same site in the catalytic domain of c-Src via a peptide- or protein-protein interaction. Our results highlight a novel and general mode of kinase regulation that may be applied not only to SFKs, but to other PTKs and Ser/Thr kinases as well.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12191618     DOI: 10.1016/s0163-7258(02)00195-x

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  5 in total

Review 1.  Seeing is believing: peptide-based fluorescent sensors of protein tyrosine kinase activity.

Authors:  David S Lawrence; Qunzhao Wang
Journal:  Chembiochem       Date:  2007-03-05       Impact factor: 3.164

2.  CSK controls retinoic acid receptor (RAR) signaling: a RAR-c-SRC signaling axis is required for neuritogenic differentiation.

Authors:  Nandini Dey; Pradip K De; Mu Wang; Hongying Zhang; Erika A Dobrota; Kent A Robertson; Donald L Durden
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

3.  Involvement of Src in the Adaptation of Cancer Cells under Microenvironmental Stresses.

Authors:  A K M Mahbub Hasan; Takashi Ijiri; Ken-Ichi Sato
Journal:  J Signal Transduct       Date:  2012-09-03

4.  GnRH Induces ERK-Dependent Bleb Formation in Gonadotrope Cells, Involving Recruitment of Members of a GnRH Receptor-Associated Signalosome to the Blebs.

Authors:  Liat Rahamim-Ben Navi; Anna Tsukerman; Alona Feldman; Philippa Melamed; Melanija Tomić; Stanko S Stojilkovic; Ulrich Boehm; Rony Seger; Zvi Naor
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-02       Impact factor: 5.555

Review 5.  Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents.

Authors:  David L Brautigan; Caroline Farrington; Goutham Narla
Journal:  Clin Sci (Lond)       Date:  2021-07-16       Impact factor: 6.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.